Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

SRx Health Solutions (SRXH) Change in Receivables (2016 - 2025)

SRx Health Solutions' Change in Receivables history spans 8 years, with the latest figure at -$3.0 million for Q2 2025.

For Q2 2025, Change in Receivables fell 282.93% year-over-year to -$3.0 million; the TTM value through Jun 2025 reached -$7.6 million, down 4588.24%, while the annual FY2023 figure was -$2.4 million, 3716.67% down from the prior year.
Change in Receivables reached -$3.0 million in Q2 2025 per SRXH's latest filing, down from -$558000.0 in the prior quarter.
In the past five years, Change in Receivables ranged from a high of $2.9 million in Q1 2022 to a low of -$5.5 million in Q4 2024.
Average Change in Receivables over 5 years is -$345055.6, with a median of -$479000.0 recorded in 2023.
Peak YoY movement for Change in Receivables: skyrocketed 588.22% in 2021, then tumbled 2225.0% in 2025.
A 5-year view of Change in Receivables shows it stood at -$752000.0 in 2021, then tumbled by 276.99% to -$2.8 million in 2022, then plummeted by 48.78% to -$4.2 million in 2023, then plummeted by 30.87% to -$5.5 million in 2024, then surged by 46.21% to -$3.0 million in 2025.
Per Business Quant, the three most recent readings for SRXH's Change in Receivables are -$3.0 million (Q2 2025), -$558000.0 (Q1 2025), and -$5.5 million (Q4 2024).